Noile-Immune Biotech Inc. (4893.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenJPY 133.00

From 52W high−33.66%

Volume161200.00

Market capJPY 5.89B

P/E (TTM)—

P/S (TTM)8236.3x

Div yield—

Key dataSep 18, 2026

Open

JPY 133.00

From 52W high

−33.66%

Volume

161200.00

Market cap

JPY 5.89B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−2.9x

P/E (TTM)

—

RSI (14)

40.3

MomentumView details →

1D Return

−1.45%

YTD Return

+3.01%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−2.9x

EV/Sales

3278.3x

P/S (TTM)

8236.3x

P/B (TTM)

1.6x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−20.17%

ROA (TTM)

−19.77%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

−28.57%

EPS YoY

+17.76%

FCF YoY

—

Revenue CAGR 3Y

−87.42%

EPS CAGR 3Y

+17.73%

EBITDA YoY

—

MomentumView details →

1D Return

−1.45%

YTD Return

+3.01%

1Y Return

−30.10%

RSI (14)

40.3

vs 50D SMA

−2.86%

vs 200D SMA

−4.83%

Capital & dividendView details →

Debt/Equity

—

Current Ratio

53.54x

Quick Ratio

53.54x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

−706.00M

Op. CF (TTM)

—

Next earningsNov 12, 2026 →

Latest newsMore news →

Noile-Immune Biotech announced its Q2 FY2026 results for January-June 2026, reporting zero revenue, an operating loss of 419 million yen, an ordinary loss of 370 million yen, and a net loss of 372 million yen.38d ago

Similar companies

Cyfuse Biomedical K.K.4892.T TMS Co.,Ltd.4891.T NIPPON CHEMIPHAR CO.,LTD.4539.T PRISM BioLab Co.,LTD206A.T Chiome Bioscience Inc.4583.T BrightPath Biotherapeutics Co.,Ltd.4594.T Find similar companies →

Latest newsMore news →

Noile-Immune Biotech announced its Q2 FY2026 results for January-June 2026, reporting zero revenue, an operating loss of 419 million yen, an ordinary loss of 370 million yen, and a net loss of 372 million yen.38d ago